Clinical Trials Logo

Clinical Trial Summary

Clinical study participation percentages haven't always been fully representative of a given demographic. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future substance abuse disorder patients during clinical trials.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05881369
Study type Observational
Source Power Life Sciences Inc.
Contact Michael B Gill
Phone 415-900-4227
Email bask@withpower.com
Status Not yet recruiting
Phase
Start date June 2024
Completion date June 2026

See also
  Status Clinical Trial Phase
Completed NCT01142986 - Evaluating Three Methods for Helping Syringe Exchangers Begin Methadone Maintenance N/A
Completed NCT03628846 - Opioid Use After Traumatic Injury in Adolescents
Completed NCT00961454 - Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major Depression Phase 1
Completed NCT02942979 - Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking
Completed NCT01142609 - Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing N/A
Withdrawn NCT00581282 - Brain Imaging Studies of the Effects of Cocaine Abstinence
Recruiting NCT05976672 - Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs N/A
Completed NCT02222909 - Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes N/A